Nkarta Inc

General ticker "NKTX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $186.2M

Nkarta Inc does not follow the US Stock Market performance with the rate: -28.5%.

Estimated limits based on current volatility of 4.3%: low 2.20$, high 2.40$

Factors to consider:

  • Current price 14.1% below estimated low
  • Earnings for 9 months up through Q3 are close to our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [2.91$, 7.95$]
  • 2024-12-30 to 2025-12-30 estimated range: [3.02$, 7.83$]

Financial Metrics affecting the NKTX estimates:

  • Negative: Non-GAAP EPS, $ of -2.40 <= 0.10
  • Negative: Operating cash flow per share per price, % of -36.06 <= 2.35
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: negative Net income
  • Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85

Similar symbols

Short-term NKTX quotes

Long-term NKTX plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $86.43MM $118.95MM $131.65MM
Operating Income $-86.43MM $-118.95MM $-131.65MM
Non-Operating Income $0.35MM $5.12MM $14.15MM
Interest Expense $0.00MM $5.59MM $0.00MM
R&D Expense $63.41MM $90.90MM $96.77MM
Income(Loss) $-86.08MM $-113.84MM $-117.50MM
Profit(Loss) $-86.08MM $-113.84MM $-117.50MM
Stockholders Equity $250.97MM $372.21MM $273.29MM
Inventory $0.00MM $4.23MM $0.00MM
Assets $273.90MM $472.94MM $378.88MM
Operating Cash Flow $-67.93MM $-57.00MM $-86.16MM
Capital expenditure $5.03MM $47.11MM $28.15MM
Investing Cash Flow $32.53MM $-184.69MM $79.02MM
Financing Cash Flow $1.20MM $219.01MM $0.69MM
Earnings Per Share* $-2.55 $-2.74 $-2.40

* EPS are Split Adjusted, recent splits may be reflected with a delay.